Global and United States Acute Migraine Treatments Market Report & Forecast 2023-2028

Report ID: 1826109 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Acute Migraine Treatments Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Acute Migraine Treatments Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Acute Migraine Treatments Market Size for the Year 2017-2028
        1.2.2 Global Acute Migraine Treatments Market Size for the Year 2017-2028
    1.3 Acute Migraine Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Acute Migraine Treatments in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Acute Migraine Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Acute Migraine Treatments Market Dynamics
        1.4.1 Acute Migraine Treatments Industry Trends
        1.4.2 Acute Migraine Treatments Market Drivers
        1.4.3 Acute Migraine Treatments Market Challenges
        1.4.4 Acute Migraine Treatments Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Acute Migraine Treatments by Type
    2.1 Acute Migraine Treatments Market Segment by Type
        2.1.1 Drugs
        2.1.2 Patches
        2.1.3 Others
    2.2 Global Acute Migraine Treatments Market Size by Type (2017, 2022 & 2028)
    2.3 Global Acute Migraine Treatments Market Size by Type (2017-2028)
    2.4 United States Acute Migraine Treatments Market Size by Type (2017, 2022 & 2028)
    2.5 United States Acute Migraine Treatments Market Size by Type (2017-2028)
3 Acute Migraine Treatments by Application
    3.1 Acute Migraine Treatments Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Drug Stores
        3.1.3 Retail Pharmacies
        3.1.4 Online Pharmacies
    3.2 Global Acute Migraine Treatments Market Size by Application (2017, 2022 & 2028)
    3.3 Global Acute Migraine Treatments Market Size by Application (2017-2028)
    3.4 United States Acute Migraine Treatments Market Size by Application (2017, 2022 & 2028)
    3.5 United States Acute Migraine Treatments Market Size by Application (2017-2028)
4 Global Acute Migraine Treatments Competitor Landscape by Company
    4.1 Global Acute Migraine Treatments Market Size by Company
        4.1.1 Top Global Acute Migraine Treatments Companies Ranked by Revenue (2021)
        4.1.2 Global Acute Migraine Treatments Revenue by Player (2017-2022)
    4.2 Global Acute Migraine Treatments Concentration Ratio (CR)
        4.2.1 Acute Migraine Treatments Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Acute Migraine Treatments in 2021
        4.2.3 Global Acute Migraine Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Acute Migraine Treatments Headquarters, Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Acute Migraine Treatments Headquarters and Area Served
        4.3.2 Global Acute Migraine Treatments Companies Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Acute Migraine Treatments Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Acute Migraine Treatments Market Size by Company
        4.5.1 Top Acute Migraine Treatments Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Acute Migraine Treatments Revenue by Players (2020, 2021 & 2022)
5 Global Acute Migraine Treatments Market Size by Region
    5.1 Global Acute Migraine Treatments Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Acute Migraine Treatments Market Size by Region (2017-2028)
        5.2.1 Global Acute Migraine Treatments Market Size by Region: 2017-2022
        5.2.2 Global Acute Migraine Treatments Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Acute Migraine Treatments Market Size YoY Growth 2017-2028
        6.1.2 North America Acute Migraine Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Acute Migraine Treatments Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Acute Migraine Treatments Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Acute Migraine Treatments Market Size YoY Growth 2017-2028
        6.3.2 Europe Acute Migraine Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Acute Migraine Treatments Market Size YoY Growth 2017-2028
        6.4.2 Latin America Acute Migraine Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Acute Migraine Treatments Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Acute Migraine Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Company Details
        7.1.2 Amgen Business Overview
        7.1.3 Amgen Acute Migraine Treatments Introduction
        7.1.4 Amgen Revenue in Acute Migraine Treatments Business (2017-2022)
        7.1.5 Amgen Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Details
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Acute Migraine Treatments Introduction
        7.2.4 Pfizer Revenue in Acute Migraine Treatments Business (2017-2022)
        7.2.5 Pfizer Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Details
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Acute Migraine Treatments Introduction
        7.3.4 Novartis Revenue in Acute Migraine Treatments Business (2017-2022)
        7.3.5 Novartis Recent Development
    7.4 Eli Lily
        7.4.1 Eli Lily Company Details
        7.4.2 Eli Lily Business Overview
        7.4.3 Eli Lily Acute Migraine Treatments Introduction
        7.4.4 Eli Lily Revenue in Acute Migraine Treatments Business (2017-2022)
        7.4.5 Eli Lily Recent Development
    7.5 AstraZeneca
        7.5.1 AstraZeneca Company Details
        7.5.2 AstraZeneca Business Overview
        7.5.3 AstraZeneca Acute Migraine Treatments Introduction
        7.5.4 AstraZeneca Revenue in Acute Migraine Treatments Business (2017-2022)
        7.5.5 AstraZeneca Recent Development
    7.6 Teva Pharmaceutical
        7.6.1 Teva Pharmaceutical Company Details
        7.6.2 Teva Pharmaceutical Business Overview
        7.6.3 Teva Pharmaceutical Acute Migraine Treatments Introduction
        7.6.4 Teva Pharmaceutical Revenue in Acute Migraine Treatments Business (2017-2022)
        7.6.5 Teva Pharmaceutical Recent Development
    7.7 Allergan
        7.7.1 Allergan Company Details
        7.7.2 Allergan Business Overview
        7.7.3 Allergan Acute Migraine Treatments Introduction
        7.7.4 Allergan Revenue in Acute Migraine Treatments Business (2017-2022)
        7.7.5 Allergan Recent Development
    7.8 Abbott
        7.8.1 Abbott Company Details
        7.8.2 Abbott Business Overview
        7.8.3 Abbott Acute Migraine Treatments Introduction
        7.8.4 Abbott Revenue in Acute Migraine Treatments Business (2017-2022)
        7.8.5 Abbott Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Acute Migraine Treatments Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Acute Migraine Treatments Market Trends
    Table 3. Acute Migraine Treatments Market Drivers
    Table 4. Acute Migraine Treatments Market Challenges
    Table 5. Acute Migraine Treatments Market Restraints
    Table 6. Global Acute Migraine Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Acute Migraine Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Acute Migraine Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Acute Migraine Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Acute Migraine Treatments Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Acute Migraine Treatments Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Acute Migraine Treatments Revenue Share by Player, 2017-2022
    Table 13. Global Acute Migraine Treatments Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Acute Migraine Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Migraine Treatments as of 2021)
    Table 15. Top Players of Acute Migraine Treatments in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Acute Migraine Treatments Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Acute Migraine Treatments Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Acute Migraine Treatments Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Acute Migraine Treatments Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Acute Migraine Treatments Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Acute Migraine Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Acute Migraine Treatments Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Acute Migraine Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Acute Migraine Treatments Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Acute Migraine Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Acute Migraine Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Acute Migraine Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Amgen Company Details
    Table 31. Amgen Business Overview
    Table 32. Amgen Acute Migraine Treatments Product
    Table 33. Amgen Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 34. Amgen Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Acute Migraine Treatments Product
    Table 38. Pfizer Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Acute Migraine Treatments Product
    Table 43. Novartis Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Eli Lily Company Details
    Table 46. Eli Lily Business Overview
    Table 47. Eli Lily Acute Migraine Treatments Product
    Table 48. Eli Lily Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 49. Eli Lily Recent Development
    Table 50. AstraZeneca Company Details
    Table 51. AstraZeneca Business Overview
    Table 52. AstraZeneca Acute Migraine Treatments Product
    Table 53. AstraZeneca Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 54. AstraZeneca Recent Development
    Table 55. Teva Pharmaceutical Company Details
    Table 56. Teva Pharmaceutical Business Overview
    Table 57. Teva Pharmaceutical Acute Migraine Treatments Product
    Table 58. Teva Pharmaceutical Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 59. Teva Pharmaceutical Recent Development
    Table 60. Allergan Company Details
    Table 61. Allergan Business Overview
    Table 62. Allergan Acute Migraine Treatments Product
    Table 63. Allergan Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 64. Allergan Recent Development
    Table 65. Abbott Company Details
    Table 66. Abbott Business Overview
    Table 67. Abbott Acute Migraine Treatments Product
    Table 68. Abbott Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million)
    Table 69. Abbott Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acute Migraine Treatments Product Picture
    Figure 2. Global Acute Migraine Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Acute Migraine Treatments Market Size 2017-2028 (US$ Million)
    Figure 4. United States Acute Migraine Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Acute Migraine Treatments Market Size 2017-2028 (US$ Million)
    Figure 6. United States Acute Migraine Treatments Market Share in Global 2017-2028
    Figure 7. Acute Migraine Treatments Report Years Considered
    Figure 8. Product Picture of Drugs
    Figure 9. Product Picture of Patches
    Figure 10. Product Picture of Others
    Figure 11. Global Acute Migraine Treatments Market Share by Type in 2022 & 2028
    Figure 12. Global Acute Migraine Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Acute Migraine Treatments Market Share by Type (2017-2028)
    Figure 14. United States Acute Migraine Treatments Market Share by Type in 2022 & 2028
    Figure 15. United States Acute Migraine Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Acute Migraine Treatments Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospital Pharmacies
    Figure 18. Product Picture of Drug Stores
    Figure 19. Product Picture of Retail Pharmacies
    Figure 20. Product Picture of Online Pharmacies
    Figure 21. Global Acute Migraine Treatments Market Share by Application in 2022 & 2028
    Figure 22. Global Acute Migraine Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Acute Migraine Treatments Market Share by Application (2017-2028)
    Figure 24. United States Acute Migraine Treatments Market Share by Application in 2022 & 2028
    Figure 25. United States Acute Migraine Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Acute Migraine Treatments Market Share by Application (2017-2028)
    Figure 27. North America Acute Migraine Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Acute Migraine Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Acute Migraine Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Acute Migraine Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Acute Migraine Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Acute Migraine Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Amgen Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 58. Eli Lily Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 59. AstraZeneca Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 60. Teva Pharmaceutical Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 61. Allergan Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 62. Abbott Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Pfizer
Novartis
Eli Lily
AstraZeneca
Teva Pharmaceutical
Allergan
Abbott
Frequently Asked Questions
Acute Migraine Treatments report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Migraine Treatments report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Migraine Treatments report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dodder Seeds

Dodder Seeds market is segmented by region (country), players, by Type and by Application. Player ... Read More

Diindolylmethane

Diindolylmethane market is segmented by region (country), players, by Type and by Application. Pl ... Read More